{"id":"W3127659442","doi":"10.1101/2021.02.01.21250769","title":"Sarilumab treatment of hospitalised patients with severe or critical COVID-19: a multinational, randomised, adaptive, phase 3, double-blind, placebo-controlled trial","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"University of Wisconsin-Madison; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Clinical endpoint; Placebo; Adverse effect; Internal medicine; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002994915,0.001273953,0.002579156,0.000313444,0.0004601784,0.00108341,0.0008111182,0.00166314,0.004975551],"category_scores_gemma":[0.001961041,0.0005233305,0.002177676,0.0003675312,0.0009761764,0.0008645472,0.0003667292,0.002351163,0.0007703336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007401511,"about_ca_system_score_gemma":0.001154284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007809834,"about_ca_topic_score_gemma":0.002121685,"domain_scores_codex":[0.9991785,0.0004875877,0.00006479307,0.0001137874,0.00005918462,0.00009615612],"domain_scores_gemma":[0.9989391,0.000299783,0.0003041223,0.00007442112,0.00009652205,0.0002859821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9739572,0.003146444,0.0009292319,0.001457317,0.001500907,0.00004617949,0.00007201768,0.000231012,0.002621459,0.0001086656,0.001176136,0.01475337],"study_design_scores_gemma":[0.9703931,0.02605662,0.001820267,0.00006361589,0.0004853904,0.00003411933,0.00001755981,0.0001916037,0.0001906095,0.00007761914,0.0006575927,0.00001180189],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9714902,0.01605752,0.000764933,0.001411328,0.0009271928,0.004824476,0.001456547,0.0001498248,0.002917919],"genre_scores_gemma":[0.9801633,0.005791484,0.001935178,0.002084936,0.0006145546,0.005486165,0.001328518,0.00002523001,0.002570571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004975551,"threshold_uncertainty_score":0.0166449,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1013100771701962,"score_gpt":0.4473318526372725,"score_spread":0.3460217754670764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}